— Know what they know.
Not Investment Advice

ATRI NASDAQ

Atrion Corporation
1W: +0.0% 1M: +0.3% 3M: +0.4% 1Y: +1.2% 3Y: -31.2% 5Y: -35.9%
$459.92
Last traded 2024-08-30 — delisted
NASDAQ · Healthcare · Medical - Instruments & Supplies · $809.4M mcap · 2M float · 1.30% daily turnover

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$169M -7.7% ▼
5Y CAGR: +2.1%
Gross Profit
$62M -17.8% ▼
5Y CAGR: -2.8%
Operating Income
$23M -13.2% ▼
5Y CAGR: -11.5%
Net Income
$19M -44.6% ▼
5Y CAGR: -10.7%
EPS (Diluted)
$11.02 -43.7% ▼
5Y CAGR: -9.8%
EBITDA
$38M -30.8% ▼
5Y CAGR: -5.8%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
Revenue$155M$148M$165M$184M$169M
YoY Growth+1.7%-4.8%+11.8%+11.2%-7.7%
Cost of Revenue$84M$81M$96M$108M$107M
Gross Profit$71M$66M$69M$76M$62M
Gross Margin45.6%44.8%42.0%41.4%36.8%
R&D Expenses$5M$6M$6M$6M$7M
SG&A Expenses$25M$25M$28M$31M$33M
Operating Expenses$30M$30M$33M$36M$40M
Operating Income$30M$23M$22M$26M$23M
Operating Margin19.0%15.4%13.1%14.2%13.3%
Interest Expense$0$0$0$0$149K
Income Before Tax$43M$38M$38M$41M$22M
Tax Expense$6M$6M$5M$6M$3M
Net Income$37M$32M$33M$35M$19M
Net Margin23.7%21.8%20.0%19.1%11.5%
EPS (Diluted)$19.73$17.44$18.18$19.56$11.02
EBITDA$51M$47M$51M$54M$38M
Shares Outstanding2M2M2M2M2M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms